LiveBain Capital to raise Rs.750 cr, by selling 2.12% holding in L&T Finance
Bain Capital through a block deal will be raising Rs.750 crore, by selling 2.12% or about a fifth of its holding in L&T Finance. Bain...
Category : Latest News
Wipro’s share buyback offer to open from November 29
Wipro will open its Rs.11,000 crore share buyback offer on November 29. It will buyback shares at Rs.320 per share, which is at a premium...
PNB Housing Finance ties up with Magicbricks to auction properties
PNB Housing Finance has partnered with Magicbricks, a realty portal for e-auction of re-possessed properties. Prasanna Singh, National Head – Collections, PNB Housing Finance said,...
Unicorn India Ventures introduces Rs.600 cr venture debt fund
Unicorn India Ventures has announced its maiden debt fund with a corpus of Rs.600 crore. It is headed by the former Sebi chief M Damodaran. As...
GSK Health appoints Navneet Saluja as Indian sub-continent head
GSK Consumer Healthcare has announced the appointment of Navneet Saluja, as the Area General Manager for India Sub-continent. GSK Consumer has brands like Horlicks, Boost, Eno,...
Airtel partners with Ericsson for developing 5G technology in India
Airtel has entered into partnership with Ericsson, to develop 5G technology for Airtel’s India operations. Nunzio Mirtillo, Ericsson’s Senior Vice President and Head of Market Area...
HFCL receives job order from BSNL for Rs.128 crore
Himachal Futuristic Communications Ltd (HFCL), telecom gearmaker has received Rs.128 crore order from Bharat Sanchar Nigam Ltd (BSNL). In a BSE filing HFCL stated, “The company...
Cipla receives USFDA approval for generic Dacogen
Cipla has received final approval for generic version of Dacogen, from the US health regulator, which is suggested for treatment of myelodysplastic syndromes. Cipla in...
Biocon facility receives inspection closure report from USFDA
Biocon has received the Establishment Inspection Report, from the USFDA with voluntary action indicated status, on closure of inspection of its aseptic drug product facility....
Eris Lifesciences to acquire Strides Shasun’s India business for Rs.500 cr
Eris Lifesciences has entered into a definitive agreement to acquire Strides Shasun, India branded generics business for a total cash consideration of Rs.500 crore. Strides...